Stocksigma LogoStocksigma Logo

Nephro Care India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 3,330 (+51.4% YoY | +14.1% QoQ) ■ EBITDA: 484 (+27.5% YoY | +33.8% QoQ) ■ EBITDA Margin (%): 14.5 (-273 bps YoY | +214 bps QoQ) ■ PAT: 276

Nephro Care India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Nephro Care India Ltd · Outcome · 12 Nov 2026, 11:22 pm

Nephro Care India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 3,330 (+51.4% YoY | +14.1% QoQ) ■ EBITDA: 484 (+27.5% YoY | +33.8% QoQ) ■ EBITDA Margin (%): 14.5 (-273 bps YoY | +214 bps QoQ) ■ PAT: 276 (+6.5% YoY | +71.6% QoQ) ■ EPS (INR): 1.67 (+6.4% YoY | +70.4% QoQ) Nephro Care India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance IPD Services ■ Revenue: 1,915 (+70.7% YoY | +22.4% QoQ) ■ EBIT: 1,125 (+26.9% YoY | +11.8% QoQ) ■ EBIT Margin (%): 58.7 (-2026 bps YoY | -555 bps QoQ) OPD Services ■ Revenue: 837 (+34.0% YoY | +10.3% QoQ) ■ EBIT: 511 (-6.7% YoY | -11.6% QoQ) ■ EBIT Margin (%): 61.1 (-2666 bps YoY | -1519 bps QoQ) Sale of medicines from pharmacy ■ Revenue: 578 (+24.2% YoY | -2.8% QoQ) ■ EBIT: 160 (+62.8% YoY | +65.1% QoQ) ■ EBIT Margin (%): 27.7 (+657 bps YoY | +1139 bps QoQ)

Original exchange filing (PDF)

More announcements from Nephro Care India Ltd

All Nephro Care India Ltd announcements